{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:20:47Z","timestamp":1789741247628,"version":"4.0.1"},"reference-count":48,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,10,29]]},"DOI":"10.3233\/jad-190577","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T07:28:06Z","timestamp":1568791686000},"page":"35-43","source":"Crossref","is-referenced-by-count":80,"title":["Neurotransmitter Imbalance in the Brain and Alzheimer\u2019s Disease Pathology"],"prefix":"10.1177","volume":"72","author":[{"given":"Stuart G.","family":"Snowden","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amera A.","family":"Ebshiana","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hye","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology and Neuroscience, Department of Old Age Psychiatry, King\u2019s College London, Maurice Wohl Clinical Neuroscience Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pletnikova","sequence":"additional","affiliation":[{"name":"Division of Neuropathology Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University Medical School, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Laboratory of Behavioural Neuroscience, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Troncoso","sequence":"additional","affiliation":[{"name":"Division of Neuropathology Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Legido-Quigley","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Thambisetty","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Laboratory of Behavioural Neuroscience, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190577_ref1","volume-title":"World Alzheimer\u2019s Report 2015. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends","author":"Prince","year":"2015"},{"key":"10.3233\/JAD-190577_ref2","first-page":"557","article-title":"Efficacy and safety of cholinesterase inhibitors in Alzheimer\u2019s disease: A meta-analysis","volume":"169","author":"Lanct\u00f4t","year":"2003","journal-title":"Can Med Assoc J"},{"key":"10.3233\/JAD-190577_ref3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bmj.331.7512.321","article-title":"Cholinesterase inhibitors for patients with Alzheimer\u2019s disease: Systematic review of randomised clinical trials","volume":"331","author":"Kaduszkiewicz","year":"2005","journal-title":"BMJ"},{"key":"10.3233\/JAD-190577_ref4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer\u2019s disease: A disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.3233\/JAD-190577_ref5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: A review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-190577_ref6","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/0024-3205(80)90176-9","article-title":"Acetylcholine and choline levels in post-mortem human brain tissue: Preliminary observations in Alzheimer\u2019s disease","volume":"26","author":"Richter","year":"1980","journal-title":"Life Sci"},{"key":"10.3233\/JAD-190577_ref7","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer\u2019s amyloid-\u03b2 oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190577_ref8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0006-3223(99)00008-6","article-title":"Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer\u2019s disease","volume":"46","author":"Raskind","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-190577_ref9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","article-title":"Free amino acid and dipeptide changes in the body fluids from Alzheimer\u2019s disease subjects","volume":"32","author":"Fonteh","year":"2007","journal-title":"Amino Acids"},{"key":"10.3233\/JAD-190577_ref10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410220110","article-title":"Alzheimer\u2019s disease: Glutamate depletion in the hippocampal perforant pathway zone","volume":"22","author":"Hyman","year":"1987","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190577_ref11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3940(98)00451-0","article-title":"Regional decreases of free d-aspartate levels in Alzheimer\u2019s disease","volume":"250","author":"D\u2019Aniello","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-190577_ref12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000106632","article-title":"The cerebellum in Alzheimer\u2019s disease","volume":"8","author":"Larner","year":"1997","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-190577_ref14","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/gerona\/63.12.1416","article-title":"The baltimore longitudinal study of aging (BLSA): A 50-year-long journey and plans for the future","volume":"63","author":"Ferrucci","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-190577_ref15","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1212\/WNL.54.11.2072","article-title":"Age-specific incidence rates of Alzheimer\u2019s disease: The Baltimore Longitudinal Study of Aging","volume":"54","author":"Kawas","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-190577_ref16","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.3233\/JAD-190577_ref17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-190577_ref18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-2009-1179","article-title":"Neuropathologic Studies of the Baltimore Longitudinal Study of Aging (BLSA)","volume":"18","author":"O\u2019Brien","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190577_ref19","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/01.wnl.0000240285.89067.3f","article-title":"Effect of a clinical stroke on the risk of dementia in a prospective cohort","volume":"67","author":"Gamaldo","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-190577_ref20","doi-asserted-by":"crossref","first-page":"e1002266","DOI":"10.1371\/journal.pmed.1002266","article-title":"Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study","volume":"14","author":"Snowden","year":"2017","journal-title":"PLoS Med"},{"key":"10.3233\/JAD-190577_ref21","doi-asserted-by":"crossref","first-page":"e0122883","DOI":"10.1371\/journal.pone.0122883","article-title":"Metabolomic method: UPLC-q-ToF polar and non-polar metabolites in the healthy rat cerebellum using an in-vial dual extraction","volume":"10","author":"Ebshiana","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190577_ref22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.ne.01.030178.001021","article-title":"Central catecholamine neuron systems: Anatomy and physiology of the dopamine systems","volume":"1","author":"Moore","year":"1978","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-190577_ref23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/brain\/awt291","article-title":"Catecholamine metabolism drives generation of mitochondrial DNA deletions in dopaminergic neurons","volume":"137","author":"Neuhaus","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-190577_ref24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.3233\/JAD-190577_ref25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0168-0102(88)90030-2","article-title":"Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex","volume":"5","author":"Sawaguchi","year":"1988","journal-title":"Neurosci Res"},{"key":"10.3233\/JAD-190577_ref26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2006.04146.x","article-title":"Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells","volume":"99","author":"Tehranian","year":"2006","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-190577_ref27","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-190577_ref28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","article-title":"Alpha-synuclein in Lewy body disease and Alzheimer\u2019s disease","volume":"9","author":"Hashimoto","year":"1999","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-190577_ref29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.3233\/JAD-190577_ref30","first-page":"10253","article-title":"Soluble \u03b1-Synuclein is a novel modulator of Alzheimer\u2019s disease pathophysiology","volume":"32","author":"Larson","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-190577_ref31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/alzrt109","article-title":"Examining the mechanisms that link \u03b2-amyloid and \u03b1-synuclein pathologies","volume":"4","author":"Marsh","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190577_ref32","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/brain\/awx074","article-title":"Repurposed drugs targeting eIF2\u03b1-P-mediated translational repression prevent neurodegeneration in mice","volume":"140","author":"Halliday","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-190577_ref33","first-page":"CD008191","article-title":"Antidepressants for psychosis and agitation in dementia","volume":"16","author":"Seitz","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-190577_ref34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-190577_ref35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jnr.10416","article-title":". Multiple aspects of homocysteine neurotoxicity: Glutamate excitotoxicity, kinase hyperactivation and DNA damage","volume":"70","author":"Ho","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-190577_ref36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0301-0082(96)00006-8","article-title":"Bioenergetics and glutamate excitotoxicity","volume":"48","author":"Greene","year":"1996","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-190577_ref37","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/jn\/130.4.1007S","article-title":"Glutamate as a neurotransmitter in the brain: Review of physiology and pathology","volume":"130","author":"Meldrum","year":"2000","journal-title":"J Nutr"},{"key":"10.3233\/JAD-190577_ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-190577_ref39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.tvjl.2005.11.007","article-title":"The role of glutamate in central nervous system health and disease \u2013 A review","volume":"173","author":"Platt","year":"2007","journal-title":"Vet J"},{"key":"10.3233\/JAD-190577_ref40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1293\/tox.21.133","article-title":"A review of glutamate receptors II: Pathophysiology and pathology","volume":"21","author":"Rousseaux","year":"2008","journal-title":"J Toxicol Pathol"},{"key":"10.3233\/JAD-190577_ref41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1293\/tox.21.25","article-title":"A review of glutamate receptors I: Current understanding of their biology","volume":"21","author":"Rousseaux","year":"2008","journal-title":"J Toxicol Pathol"},{"key":"10.3233\/JAD-190577_ref42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/syn.20472","article-title":"Memantine agonist action at dopamine D2High receptors","volume":"62","author":"Seeman","year":"2008","journal-title":"Synapse"},{"key":"10.3233\/JAD-190577_ref43","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuroimage.2015.11.018","article-title":"Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate","volume":"125","author":"Janik","year":"2016","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-190577_ref44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.aac4690","article-title":"Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons","volume":"350","author":"Kim","year":"2015","journal-title":"Science"},{"key":"10.3233\/JAD-190577_ref45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/acta.0.0930149","article-title":"Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man","volume":"93","author":"Cavagnini","year":"1980","journal-title":"Acta Endocrinol"},{"key":"10.3233\/JAD-190577_ref46","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1523\/JNEUROSCI.23-06-02040.2003","article-title":"Neuronal glutamate uptake contributes to GABA synthesis and inhibitory synaptic strength","volume":"23","author":"Mathews","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190577_ref47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1471-4159.1982.tb07963.x","article-title":"4-aminobutyraldehyde dehydrogenase activity in rat brain","volume":"39","author":"Tago","year":"1982","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-190577_ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1104\/pp.115.1.1","article-title":"The metabolism and functions of [gamma]-aminobutyric acid","volume":"115","author":"Bown","year":"1997","journal-title":"Plant Physiol"},{"key":"10.3233\/JAD-190577_ref49","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/jm9904349","article-title":"GABA-activated ligand gated ion channels: Medicinal chemistry and molecular biology","volume":"43","author":"Chebib","year":"2000","journal-title":"J Med Chem"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:53Z","timestamp":1777370813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":48,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-190577","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]}}}